The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Measurement of Fibrinopeptide A in Human Blood
Open accessAbstract
Since thrombin cleaves fibrinopeptides A (FPA) and B from the NH(2)-terminal end of the fibrinogen molecule, measurement of fibrinopeptide levels in plasma may provide a direct index of thrombin action. Recently a radioimmunoassay for FPA has been developed, and in the present paper, we describe the application of this assay to the measurement of FPA levels in clinical blood samples. Since fibrinogen cross-reacts with antibodies to FPA, dialysis was used to extract the peptide from plasma. In vitro generation of FPA was prevented by removing the fibrinogen from the plasma by precipitation with ethanol before dialysis. The processing technique permitted recovery of 75% of FPA added to blood in vitro. Evidence that the immunoreactivity measured in plasma is due to FPA was provided by the results of experiments in which two antisera to FPA with different specificities showed comparable results and addition of thrombin caused no change in immunoreactivity. In contrast, extracts of streptokinasetreated plasma showed a five-fold increase in activity when treated with thrombin and markedly different immunoreactivity with the two antisera. Plasma FPA levels in 30 normal men were below 2 ng/ml, with a mean of 0.5 ng/ml. FPA levels in 12 patients with reduced fibrinogen levels or reduced platelet counts or both ranged between 4 and 289 ng/ml. FPA levels in 13 patients with normal or elevated fibrinogen levels, including 6 patients with clinical evidence of venous thrombosis or pulmonary embolism or both, ranged between 5 and 23 ng/ml. FPA and fibrinogen degradation product levels did not correlate, and in several patients, elevated FPA levels were found in the presence of normal fibrinogen degradation product levels. After infusion of FPA-containing solutions in four normal individuals, FPA showed a disappearance rate from the plasma consistent with a t((1/2)) of 3-5 min. Heparin infusions in six patients with venous thrombosis or pulmonary embolism or both and elevated FPA levels were followed by a prompt decline in FPA level at a mean rate equivalent to a 3-5 min t((1/2)).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new method for the determination of fibrinogen in small samples of plasma.
Ratnoff, O. D., & Menzie, C. M. (1951) · PubMed · Cited by 1,046
Antibodies to Bradykinin and Angiotensin: A Use of Carbodiimides in Immunology
Goodfriend, T. L., Levine, L., & Fasman, G. D. (1964) · Science · doi:10.1126/science.144.3624.1344 · Cited by 807
Merrifield, R. B. (1969) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470122778.ch6 · Cited by 638
Human fibrinopeptides isolation, characterization and structure
Blombäck, B., Blombäck, M., Edman, P., & Hessel, B. (1966) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(66)90437-5 · Cited by 426
A Rapid, Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum
Merskey, C., Lalezari, P., & Johnson, A. J. (1969) · Experimental Biology and Medicine · doi:10.3181/00379727-131-33998 · Cited by 415
A quick and accurate method for the determination of fibronogen in plasma.
Ellis, B., & Stransky, A. W. (1961) · PubMed · Cited by 249
Iwanaga, S., WallEN, P., GrONDAHL, N. J., Henschen, A., & BlombACK, B. (1969) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1969.tb00514.x · Cited by 192
Merrifield, R. B. (1973) · Springer eBooks · doi:10.1007/978-1-4613-4571-8_16 · Cited by 154
Astrup, T. (1958) · PubMed · Cited by 99
Detection of serum fibrinogen and fibrin degradation products
Marder, V. J., Matchett, M. O., & Sherry, S. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90325-1 · Cited by 84
Activated Coagulation Factors: In‐Vivo and in‐Vitro Studies
Niemetz, J., & Nossel, H. L. (1969) · British Journal of Haematology · doi:10.1111/j.1365-2141.1969.tb00411.x · Cited by 64
Self-citation
Cited by
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of Transglutaminases
Folk, J. E., & Finlayson, J. S. (1977) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60217-x · Cited by 814
Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.
Merlini, P. A., Bauer, K. A., Oltrona, L., Ardissino, D., Cattaneo, M., Belli, C., Mannucci, P. M., & Rosenberg, R. D. (1994) · Circulation · doi:10.1161/01.cir.90.1.61 · Cited by 597
Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery
Salzman, E. W., Weinstein, M. J., Weintraub, R. M., Ware, J. A., Thurer, R. L., Robertson, L., Donovan, A., Gaffney, T., Bertele, V., Troll, J., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605293142202 · Cited by 504
A two-step fibrinogen–fibrin transition in blood coagulation
Blombäck, B., Hessel, B., Hogg, D., & Therkildsen, L. (1978) · Nature · doi:10.1038/275501a0 · Cited by 476
Metadata
- Authors
- Nossel, H. L., Yudelman, I., Canfield, R. E., Butler, V. P., Spanondis, K., Wilner, G. D., & Qureshi, G. D.
- Venue
- Journal of Clinical Investigation
- Published
- 1974-07-01
- Volume
- 54
- Issue
- 1
- Pages
- 43-53
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2159162837
- Cited by
- 531
- References
- 11
- FWCI
- 25.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.